b72.3 (Biogenex)
90
Structured Review
Biogenex
b72.3
B72.3, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b72.3/product/Biogenex
Average 90 stars, based on 1 article reviews
B72.3, supplied by Biogenex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b72.3/product/Biogenex
Average 90 stars, based on 1 article reviews
b72.3 - by Bioz Stars,
2026-03
90/100 stars
Images
1) Product Images from "Immunocytochemistry of effusions: Processing and commonly used immunomarkers"
Article Title: Immunocytochemistry of effusions: Processing and commonly used immunomarkers
Journal: CytoJournal
doi: 10.25259/CMAS_02_15_2021
Figure Legend Snippet: Immunomarkers of interest for immunocytochemical evaluation of effusion fluids (in alphabetical order).
Techniques Used:
Figure Legend Snippet: Details of antibodies (for immunocytochemistry on formalin-fixed paraffin-embedded sections of cell-blocks) (in alphabetic order).
Techniques Used: Immunocytochemistry, Formalin-fixed Paraffin-Embedded, Incubation
![B72.3 immunoreactivity pattern (metastatic mammary adenocarcinoma, pleural fluid). Metastatic adenocarcinoma cells (red arrow NC) show a cytoplasmic immunoreactivity pattern. [a, Immunostained cell-block section (a, 40X).]](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_9319/pmc09079319/pmc09079319__Cytojournal-19-6-g003.jpg "B72.3 immunoreactivity pattern (metastatic mammary adenocarcinoma, pleural fluid). Metastatic ...")
Figure Legend Snippet: B72.3 immunoreactivity pattern (metastatic mammary adenocarcinoma, pleural fluid). Metastatic adenocarcinoma cells (red arrow NC) show a cytoplasmic immunoreactivity pattern. [a, Immunostained cell-block section (a, 40X).]
Techniques Used: Blocking Assay
![Comparison of immunoreactivity with BerEP4 and B72.3 (metastatic mammary adenocarcinoma, pleural fluid). (a,b) Most of the adenocarcinoma cells (red arrows NC) show strong membranous BerEP4 immunoreactivity. (c,d) Compared to this, B72.3 immunoreactivity is absent in most of these neoplastic cells (blue arrows NC) with immunoreactivity in rare neoplastic cells (arrowheads). [a–d, Immunostained cell-block section (a,c, 20X; b,d, 40X).]](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_9319/pmc09079319/pmc09079319__Cytojournal-19-6-g004.jpg "Comparison of immunoreactivity with BerEP4 and B72.3 (metastatic mammary adenocarcinoma, pleural fluid). (a,b) Most of ...")
Figure Legend Snippet: Comparison of immunoreactivity with BerEP4 and B72.3 (metastatic mammary adenocarcinoma, pleural fluid). (a,b) Most of the adenocarcinoma cells (red arrows NC) show strong membranous BerEP4 immunoreactivity. (c,d) Compared to this, B72.3 immunoreactivity is absent in most of these neoplastic cells (blue arrows NC) with immunoreactivity in rare neoplastic cells (arrowheads). [a–d, Immunostained cell-block section (a,c, 20X; b,d, 40X).]
Techniques Used: Blocking Assay